Main Menu

Leemore Dafny testifies before Congress on anticompetitive consolidation in the healthcare market

April 2021

On April 29, 2021, Academic Affiliate Leemore Dafny testified before the US House Subcommittee on Antitrust, Commercial, and Administrative Law. In her testimony, “How Health Care Consolidation Is Contributing to Higher Prices and Spending, and Reforms That Could Bolster Antitrust Enforcement and Preserve and Promote Competition in Health Care Markets,” Dr. Dafny testified that high and rising provider prices are driving higher healthcare spending and that the pandemic should not delay actions to prevent anticompetitive consolidation. Dr. Dafny also outlined several reforms that could bolster antitrust enforcement and preserve and promote competition in healthcare markets

Read Dr. Dafny’s testimony here.

Subsequent to her testimony, Dr. Dafny published the related article “The Covid-19 Pandemic Should Not Delay Actions to Prevent Anticompetitive Consolidation in US Health Care Markets” in Promarket, the publication of the Stigler Center at the University of Chicago–Booth School of Business. Click here to read the article.

Jump to Page